Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

被引:0
|
作者
Tomokazu Tamura
Takashi Irie
Sayaka Deguchi
Hisano Yajima
Masumi Tsuda
Hesham Nasser
Keita Mizuma
Arnon Plianchaisuk
Saori Suzuki
Keiya Uriu
Mst Monira Begum
Ryo Shimizu
Michael Jonathan
Rigel Suzuki
Takashi Kondo
Hayato Ito
Akifumi Kamiyama
Kumiko Yoshimatsu
Maya Shofa
Rina Hashimoto
Yuki Anraku
Kanako Terakado Kimura
Shunsuke Kita
Jiei Sasaki
Kaori Sasaki-Tabata
Katsumi Maenaka
Naganori Nao
Lei Wang
Yoshitaka Oda
Terumasa Ikeda
Akatsuki Saito
Keita Matsuno
Jumpei Ito
Shinya Tanaka
Kei Sato
Takao Hashiguchi
Kazuo Takayama
Takasuke Fukuhara
机构
[1] Hokkaido University,Department of Microbiology and Immunology, Faculty of Medicine
[2] Hokkaido University,Graduate School of Medicine
[3] Hokkaido University,School of Medicine
[4] Hokkaido University,Institute for the Advancement of Higher Education
[5] Hokkaido University,Institute for Vaccine Research and Development (IVReD)
[6] Hokkaido University,One Health Research Center
[7] Hiroshima University,Graduate School of Biomedical and Health Sciences
[8] Kyoto University,Center for iPS Cell Research and Application (CiRA)
[9] Kyoto University,Laboratory of Medical Virology, Institute for Life and Medical Sciences
[10] Hokkaido University,Department of Cancer Pathology, Faculty of Medicine
[11] Hokkaido University,Institute for Chemical Reaction Design and Discovery (WPI
[12] Kumamoto University,ICReDD)
[13] Suez Canal University,Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection
[14] Hokkaido University,Department of Clinical Pathology, Faculty of Medicine
[15] The University of Tokyo,Division of Risk Analysis and Management, International Institute for Zoonosis Control
[16] The University of Tokyo,Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science
[17] Hokkaido University,Graduate School of Medicine
[18] University of Miyazaki,Institute for Genetic Medicine
[19] University of Miyazaki,Department of Veterinary Science, Faculty of Agriculture
[20] Hokkaido University,Graduate School of Medicine and Veterinary Medicine
[21] Kyushu University,Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences
[22] Hokkaido University,Department of Medicinal Sciences, Graduate School of Pharmaceutical Sciences
[23] Hokkaido University,Division of Pathogen Structure, International Institute for Zoonosis Control
[24] Hokkaido University,Global Station for Biosurfaces and Drug Discovery
[25] University of Miyazaki,Division of International Research Promotion, International Institute for Zoonosis Control
[26] Hokkaido University,Center for Animal Disease Control
[27] The University of Tokyo,International Collaboration Unit, International Institute for Zoonosis Control
[28] The University of Tokyo,International Research Center for Infectious Diseases, The Institute of Medical Science
[29] CREST,Graduate School of Frontier Sciences
[30] Japan Science and Technology Agency,International Vaccine Design Center, The Institute of Medical Science
[31] The University of Tokyo,Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection
[32] Kumamoto University,Kyoto University Immunomonitoring Center
[33] Kyoto University,Laboratory of Virus Control, Research Institute for Microbial Diseases
[34] AMED-CREST,Division of Molecular Pathobiology, International Institute for Zoonosis Control
[35] Japan Agency for Medical Research and Development (AMED),School of Medicine
[36] Osaka University,Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection
[37] Hokkaido University,undefined
[38] Kobe University,undefined
[39] Tokyo Metropolitan Institute of Public Health,undefined
[40] Tokai University School of Medicine,undefined
[41] Kyoto University,undefined
[42] Kumamoto University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5.
引用
收藏
相关论文
共 50 条
  • [1] Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
    Tamura, Tomokazu
    Irie, Takashi
    Deguchi, Sayaka
    Yajima, Hisano
    Tsuda, Masumi
    Nasser, Hesham
    Mizuma, Keita
    Plianchaisuk, Arnon
    Suzuki, Saori
    Uriu, Keiya
    Begum, Mst Monira
    Shimizu, Ryo
    Jonathan, Michael
    Suzuki, Rigel
    Kondo, Takashi
    Ito, Hayato
    Kamiyama, Akifumi
    Yoshimatsu, Kumiko
    Shofa, Maya
    Hashimoto, Rina
    Anraku, Yuki
    Kimura, Kanako Terakado
    Kita, Shunsuke
    Sasaki, Jiei
    Sasaki-Tabata, Kaori
    Maenaka, Katsumi
    Nao, Naganori
    Wang, Lei
    Oda, Yoshitaka
    Sawa, Hirofumi
    Kawabata, Ryoko
    Watanabe, Yukio
    Sakamoto, Ayaka
    Yasuhara, Naoko
    Suzuki, Tateki
    Nakajima, Yukari
    Ferdous, Zannatul
    Shishido, Kenji
    Mugita, Yuka
    Takahashi, Otowa
    Ichihara, Kimiko
    Kaku, Yu
    Misawa, Naoko
    Guo, Ziyi
    Hinay, Alfredo, Jr.
    Kosugi, Yusuke
    Fujita, Shigeru
    Tolentino, Jarel M.
    Chen, Luo
    Pan, Lin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [2] SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects
    Channabasappa, Nikhil K.
    Niranjan, Ankush K.
    Emran, Talha B.
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 1054 - 1055
  • [3] Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
    Yamasoba, Daichi
    Uriu, Keiya
    Plianchaisuk, Arnon
    Kosugi, Yusuke
    Pan, Lin
    Zahradnik, Jiri
    Ito, Jumpei
    Sato, Kei
    LANCET INFECTIOUS DISEASES, 2023, 23 (06): : 655 - 656
  • [4] XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
    Islam, Md. Aminul
    Kaifa, Fatema Hasan
    Chandran, Deepak
    Bhattacharya, Manojit
    Chakraborty, Chiranjib
    Bhattacharya, Prosun
    Dhama, Kuldeep
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [5] Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
    Uriu, Keiya
    Ito, Jumpei
    Zahradnik, Jiri
    Fujita, Shigeru
    Kosugi, Yusuke
    Schreiber, Gideon
    Sato, Kei
    LANCET INFECTIOUS DISEASES, 2023, 23 (03): : 280 - 281
  • [6] XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2
    Popovic, Marko E.
    MICROBIOLOGICAL RESEARCH, 2023, 270
  • [7] Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
    Tomokazu Tamura
    Jumpei Ito
    Keiya Uriu
    Jiri Zahradnik
    Izumi Kida
    Yuki Anraku
    Hesham Nasser
    Maya Shofa
    Yoshitaka Oda
    Spyros Lytras
    Naganori Nao
    Yukari Itakura
    Sayaka Deguchi
    Rigel Suzuki
    Lei Wang
    MST Monira Begum
    Shunsuke Kita
    Hisano Yajima
    Jiei Sasaki
    Kaori Sasaki-Tabata
    Ryo Shimizu
    Masumi Tsuda
    Yusuke Kosugi
    Shigeru Fujita
    Lin Pan
    Daniel Sauter
    Kumiko Yoshimatsu
    Saori Suzuki
    Hiroyuki Asakura
    Mami Nagashima
    Kenji Sadamasu
    Kazuhisa Yoshimura
    Yuki Yamamoto
    Tetsuharu Nagamoto
    Gideon Schreiber
    Katsumi Maenaka
    Takao Hashiguchi
    Terumasa Ikeda
    Takasuke Fukuhara
    Akatsuki Saito
    Shinya Tanaka
    Keita Matsuno
    Kazuo Takayama
    Kei Sato
    Nature Communications, 14
  • [8] Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
    Tamura, Tomokazu
    Ito, Jumpei
    Uriu, Keiya
    Zahradnik, Jiri
    Kida, Izumi
    Anraku, Yuki
    Nasser, Hesham
    Shofa, Maya
    Oda, Yoshitaka
    Lytras, Spyros
    Nao, Naganori
    Itakura, Yukari
    Deguchi, Sayaka
    Suzuki, Rigel
    Wang, Lei
    Begum, M. S. T. Monira
    Kita, Shunsuke
    Yajima, Hisano
    Sasaki, Jiei
    Sasaki-Tabata, Kaori
    Shimizu, Ryo
    Tsuda, Masumi
    Kosugi, Yusuke
    Fujita, Shigeru
    Pan, Lin
    Sauter, Daniel
    Yoshimatsu, Kumiko
    Suzuki, Saori
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Schreiber, Gideon
    Maenaka, Katsumi
    Hashiguchi, Takao
    Ikeda, Terumasa
    Fukuhara, Takasuke
    Saito, Akatsuki
    Tanaka, Shinya
    Matsuno, Keita
    Takayama, Kazuo
    Sato, Kei
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [9] Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike
    Fang, Liaoxin
    Kang, Xiaofeng
    Hong, Qian
    Xue, Chunyuan
    Pan, Lu
    Chen, Jiaxin
    Tang, Chuanhao
    Sun, Liying
    Xu, Xiaojie
    Yuan, Jing
    Du, Yimeng
    Xu, An
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (23) : 29716 - 29727
  • [10] Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York
    Gambaro, Fabiana
    Duerr, Ralf
    Dimartino, Dacia
    Marier, Christian
    Iturrate, Eduardo
    Mulligan, Mark J.
    Heguy, Adriana
    Dellicour, Simon
    VIRUS EVOLUTION, 2024, 10 (01)